Musical chairs as Novartis UK exec becomes Cipla CEO, Glenmark COO moves to Aurobindo
This article was originally published in Scrip
Executive Summary
Two large Indian generic companies, Cipla and Aurobindo, have announced top-level appointments, roping in executives with more than two decades of experience each to take charge as their respective chief executive officers (CEOs).